why choose us

First received: May 03, 2024

Clinical Trial: Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes Mellitus, Type 2

Study Type: INTERVENTIONAL


Official Title: Effect of CagriSema, Semaglutide and Cagrilintide on Insulin Sensitivity and Pancreatic Endocrine Function in Adults With Type 2 Diabetes

Brief Summary: This study will look at how CagriSema, semaglutide and cagrilintide regulate insulin effects in the body of people with type 2 diabetes (T2D).CagriSema is a new investigational medicine that combines two medicines called cagrilintide and semaglutide.Doctors may not yet prescribe CagriSema.Participants will either get CagriSema, semaglutide, cagrilintide, or a ''dummy'' medicine.Which treatment the participants will get is decided by chance.Participants will get the study medicine together with…

Read more